NCT06158620View on ClinicalTrials.gov

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

December 1, 2026

Conditions
Post Operative PainUrolithiasisUreter CalculiStent Complication
Interventions
DRUG

intra-nasal ketorolac

Experimental group receiving intra-nasal ketorolac for management of post-operative pain following ureteroscopy for kidney stone, and associated ureter stent discomfort.

DRUG

oral diclofenac

Control group to receive oral diclofenac, which is a comparable medication to intra-nasal ketorolac.

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

assertio Therapeutics, Inc

UNKNOWN

lead

University of Texas Southwestern Medical Center

OTHER

NCT06158620 - Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease | Biotech Hunter | Biotech Hunter